IBrC patients with lymph node involvement (N1) demonstrated a significantly lower level of PAI-1 antigen than patients with free lymph node metastases (N0) (p = 0.0412). This evidence concerns the gene SERPINE1 and metastatic malignant neoplasm in the lymph nodes.